Kronos Bio Inc. (KRON) NASDAQ

$3.36 -0.05 (-1.47%)

Market Cap: $193.46M

As of 05/25/22 04:00 PM EDT. Market closed.

(KRON)

Kronos Bio Inc. (KRON) NASDAQ

$3.36 -0.05 (-1.47%)

Market Cap: $193.46M

As of 05/25/22 04:00 PM EDT. Market closed.

Kronos Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing therapies that seek to transform the lives of those affected by cancer. The company focuses on targeting dysregulated transcription factors and the regulatory networks within cells that drive cancerous growth. Kronos Bio’s lead investigational therapy is entospletinib, a selective inhibitor ... read more

Kronos Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing therapies that seek to transform the lives of those affected by cancer. The company focuses on targeting dysregulated transcription factors and the regulatory networks within cells that drive cancerous growth. Kronos Bio’s lead investigational therapy is entospletinib, a selective inhibitor targeting spleen tyrosine kinase (SYK) in development for the frontline treatment of NPM1-mutated acute myeloid leukemia (AML). The company is also developing KB-0742, an oral inhibitor of cyclin dependent kinase 9 (CDK9), for the treatment of MYC-amplified solid tumors. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
63
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$3.37
Previous Close
$3.41
Days Range
$3.21 - $3.55
52 week range
$3.37 - $28.42
Volume
506,636
Avg. Volume (30 days)
647,045
Market Cap
$193.46M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,732,201
Open
$3.37
Previous Close
$3.41
Days Range
$3.21 - $3.55
52 week range
$3.37 - $28.42
Volume
506,636
Avg. Volume (30 days)
647,045
Market Cap
$193.46M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,732,201

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR KRONOS BIO INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
BISCHOFBERGER NORBERT W President & CEO May 18, 2022 Buy $3.72 206,198 768,046 509,609 May 19, 2022, 06:03 PM
BISCHOFBERGER NORBERT W President & CEO May 17, 2022 Buy $3.83 90,931 348,529 303,411 May 19, 2022, 06:03 PM
BISCHOFBERGER NORBERT W President & CEO May 19, 2022 Buy $3.78 300,000 1,134,510 809,609 May 19, 2022, 06:03 PM
Dinsmore Christopher Chief Scientific Officer Dec 13, 2021 Sale $12.37 11,386 140,845 85,148 Dec 15, 2021, 05:08 PM
DiMartino Jorge Chief Medical Officer & VP Dec 13, 2021 Sale $12.37 16,402 202,893 117,785 Dec 15, 2021, 05:06 PM
BISCHOFBERGER NORBERT W President & CEO Dec 06, 2021 Buy $12.09 14,356 173,492 212,480 Dec 08, 2021, 06:21 PM
De Backer Marianne Director Dec 01, 2021 Buy $11.57 1,150 13,305 2,750 Dec 02, 2021, 05:12 PM
Dinsmore Christopher Chief Scientific Officer Oct 04, 2021 Option Exercise $3.27 9,189 30,048 105,549 Oct 04, 2021, 06:24 PM
Dinsmore Christopher Chief Scientific Officer Oct 04, 2021 Sale $20.81 9,189 191,195 96,360 Oct 04, 2021, 06:24 PM
Dinsmore Christopher Chief Scientific Officer Sep 07, 2021 Option Exercise $3.27 9,189 30,048 105,549 Sep 09, 2021, 01:23 PM
Dinsmore Christopher Chief Scientific Officer Sep 07, 2021 Sale $21.91 9,189 201,302 96,360 Sep 09, 2021, 01:23 PM
De Backer Marianne Director Aug 20, 2021 Buy $19.56 1,000 19,565 1,600 Aug 24, 2021, 07:24 PM
Dinsmore Christopher Chief Scientific Officer Aug 02, 2021 Option Exercise $3.27 9,189 30,048 105,549 Aug 03, 2021, 05:13 PM
Dinsmore Christopher Chief Scientific Officer Aug 02, 2021 Sale $20.59 9,189 189,165 96,360 Aug 03, 2021, 05:13 PM
Loven Jakob Director Apr 20, 2021 Sale $20.10 21,551 433,185 1,301,556 Apr 20, 2021, 06:59 PM
Loven Jakob Director Apr 19, 2021 Sale $20.59 14,004 288,278 1,327,245 Apr 20, 2021, 06:59 PM
Loven Jakob Director Apr 16, 2021 Sale $21.01 33,162 696,762 1,344,962 Apr 20, 2021, 06:59 PM
Loven Jakob Director Apr 15, 2021 Sale $21.78 24,818 540,536 1,370,254 Apr 15, 2021, 06:57 PM
Loven Jakob Director Apr 14, 2021 Sale $22.80 32,636 744,029 1,414,010 Apr 15, 2021, 06:57 PM
Loven Jakob Director Apr 13, 2021 Sale $23.84 17,020 405,793 1,434,731 Apr 15, 2021, 06:57 PM
Loven Jakob Director Apr 08, 2021 Sale $27.41 63,128 1,730,487 1,507,032 Apr 12, 2021, 08:33 PM
Loven Jakob Director Apr 12, 2021 Sale $26.28 15,828 415,896 1,444,828 Apr 12, 2021, 08:33 PM
Loven Jakob Director Apr 09, 2021 Sale $27.20 21,660 589,152 1,460,556 Apr 12, 2021, 08:33 PM
Omega Fund V, L.P. 10% Owner Oct 14, 2020 Option Exercise $16.15 366,299 5,915,729 3,368,283 Oct 16, 2020, 03:58 PM
Omega Fund V, L.P. 10% Owner Oct 14, 2020 Buy $19.00 450,000 8,550,000 3,818,283 Oct 16, 2020, 03:58 PM
Stampacchia Otello Director Oct 14, 2020 Option Exercise $16.15 366,299 5,915,729 3,368,283 Oct 16, 2020, 03:56 PM
Stampacchia Otello Director Oct 14, 2020 Buy $19.00 450,000 8,550,000 3,818,283 Oct 16, 2020, 03:56 PM
TANEN DAVID M Director Oct 14, 2020 Option Exercise $16.15 37,119 599,472 471,230 Oct 16, 2020, 03:54 PM
Ridloff Elena Director Oct 14, 2020 Buy $19.00 2,630 49,970 2,630 Oct 16, 2020, 03:52 PM
MARTIN JOHN C Director Oct 14, 2020 Option Exercise $16.15 205,260 3,314,949 1,876,564 Oct 16, 2020, 03:51 PM
MARTIN JOHN C Director Oct 14, 2020 Buy $19.00 75,800 1,440,200 1,952,364 Oct 16, 2020, 03:51 PM
Loven Jakob Director Oct 14, 2020 Option Exercise $16.15 169,031 2,729,851 1,545,344 Oct 16, 2020, 03:49 PM
Belldegrun Arie Director Oct 14, 2020 Option Exercise $16.15 253,251 4,090,004 2,315,314 Oct 16, 2020, 03:44 PM
Kosacz Barbara COO & General Counsel Oct 14, 2020 Buy $19.00 5,250 99,750 614,600 Oct 16, 2020, 03:40 PM
Dinsmore Christopher Chief Scientific Officer Oct 14, 2020 Buy $19.00 5,250 99,750 5,250 Oct 16, 2020, 03:39 PM
Al-Wakeel Yasir B. Chief Financial Officer Oct 14, 2020 Buy $19.00 5,250 99,750 37,219 Oct 16, 2020, 03:38 PM
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust 10% Owner Oct 14, 2020 Option Exercise $16.15 185,758 2,999,992 4,274,996 Oct 16, 2020, 03:36 PM
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust 10% Owner Oct 14, 2020 Buy $19.00 95,500 1,814,500 4,370,496 Oct 16, 2020, 03:36 PM
BISCHOFBERGER NORBERT W President & CEO Oct 14, 2020 Option Exercise $16.15 185,758 2,999,992 4,274,996 Oct 16, 2020, 03:29 PM
BISCHOFBERGER NORBERT W President & CEO Oct 14, 2020 Buy $19.00 95,500 1,814,500 4,370,496 Oct 16, 2020, 03:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
BISCHOFBERGER NORBERT W President & CEO 05/18/2022 768,046
BISCHOFBERGER NORBERT W President & CEO 05/17/2022 348,529
BISCHOFBERGER NORBERT W President & CEO 05/19/2022 1,134,510
Dinsmore Christopher Chief Scientific Officer 12/13/2021 140,845
DiMartino Jorge Chief Medical Officer & VP 12/13/2021 202,893
BISCHOFBERGER NORBERT W President & CEO 12/06/2021 173,492
De Backer Marianne Director 12/01/2021 13,305
Dinsmore Christopher Chief Scientific Officer 10/04/2021 30,048
Dinsmore Christopher Chief Scientific Officer 10/04/2021 191,195
Dinsmore Christopher Chief Scientific Officer 09/07/2021 30,048
Dinsmore Christopher Chief Scientific Officer 09/07/2021 201,302
De Backer Marianne Director 08/20/2021 19,565
Dinsmore Christopher Chief Scientific Officer 08/02/2021 30,048
Dinsmore Christopher Chief Scientific Officer 08/02/2021 189,165
Loven Jakob Director 04/20/2021 433,185
Loven Jakob Director 04/19/2021 288,278
Loven Jakob Director 04/16/2021 696,762
Loven Jakob Director 04/15/2021 540,536
Loven Jakob Director 04/14/2021 744,029
Loven Jakob Director 04/13/2021 405,793
Loven Jakob Director 04/08/2021 1,730,487
Loven Jakob Director 04/12/2021 415,896
Loven Jakob Director 04/09/2021 589,152
Omega Fund V, L.P. 10% Owner 10/14/2020 5,915,729
Omega Fund V, L.P. 10% Owner 10/14/2020 8,550,000
Stampacchia Otello Director 10/14/2020 5,915,729
Stampacchia Otello Director 10/14/2020 8,550,000
TANEN DAVID M Director 10/14/2020 599,472
Ridloff Elena Director 10/14/2020 49,970
MARTIN JOHN C Director 10/14/2020 3,314,949
MARTIN JOHN C Director 10/14/2020 1,440,200
Loven Jakob Director 10/14/2020 2,729,851
Belldegrun Arie Director 10/14/2020 4,090,004
Kosacz Barbara COO & General Counsel 10/14/2020 99,750
Dinsmore Christopher Chief Scientific Officer 10/14/2020 99,750
Al-Wakeel Yasir B. Chief Financial Officer 10/14/2020 99,750
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust 10% Owner 10/14/2020 2,999,992
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust 10% Owner 10/14/2020 1,814,500
BISCHOFBERGER NORBERT W President & CEO 10/14/2020 2,999,992
BISCHOFBERGER NORBERT W President & CEO 10/14/2020 1,814,500
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2021
03/31/2021
0.33%
1Q

Period of Report: 06/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
0.33%
1Q